SubHero Banner
Text

Caplyta® (lumateperone) – New dosage strengths

April 25, 2022 - Intra-Cellular Therapies announced the FDA approval of new dosage strengths of Caplyta (lumateperone), 10.5 mg and 21 mg capsules, for specific patient populations.

Download PDF